| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2012: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2011: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
|
|---|
| Research Abstract |
This study evaluated the safety and tolerability of polyphenols in patients with Alzheimer’s disease. This is a uni-center, double-blind, randomized, placebo-controlled clinical trial of 48 weeks. Primary outcome measure is safety and tolerability of polyphenols. We have started polyphenol capsules administration in 14 patients. No significant adverse events have not been reported by any of the patients due to study treatment until May 2013. Oral administration of polyphenols will appearto be safe in patients with Alzheimer’s disease.
|
